Welcome to Illuminate
ILLUMINATE aims to transform the approach to theranostics-based advanced stage cancer treatment while increasing the overall availability of the radioisotope lutetium.
15
European partners in consortium
21 million
Budget in Euros (including in-kind contributions from industry)
4,5 years
Project duration
Start
October 1, 2024
